Related Experiment Video
Updated: May 6, 2026

10:10
Development of a Lateral Flow Immunochromatographic Strip for Rapid and Quantitative Detection of Small Molecule Compounds
Published on: November 13, 2021
9.1K
An automatic enzyme immunoassay based on a chemiluminescent lateral flow immunosensor
Hyou-Arm Joung1, Young Kyoung Oh, Min-Gon Kim
1School of Physics and Chemistry, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea.
Biosensors & Bioelectronics
|November 2, 2013
Summary
This study introduces a novel chemiluminescent lateral flow immunosensor for enzyme immunoassay (EIA) that simplifies point-of-care testing. It eliminates complex fluidic controls, enabling sensitive detection with a single sample injection.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Biosensors
Background:
- Microfluidic enzyme immunoassay (EIA) sensors offer efficient point-of-care testing (POCT).
- Current systems are expensive and require complex manufacturing and fluidic control.
- Lateral flow immunosensor (LFI) strips need additional steps for EIA implementation.
Purpose of the Study:
- To develop a novel LFI-based EIA sensor that eliminates the need for mechanical fluidic control, washing, or injection steps.
- To integrate a delayed-release mechanism for chemiluminescence substrates using an asymmetric polysulfone membrane (ASPM).
- To create a fully automated chemiluminescent LFI-EIA system for simplified POCT.
Main Methods:
- An asymmetric polysulfone membrane (ASPM) was utilized to control the delayed release of chemiluminescence substrates (luminol enhancer and hydrogen peroxide generator).
- The ASPM was positioned between the nitrocellulose (NC) membrane and the substrate pad, enabling substrate release after 5.3 ± 0.3 minutes.
- A chemiluminescent LFI-based automatic EIA system was designed and implemented, integrating immunoreaction, pH change, substrate release, and chemiluminescent reaction.
Main Results:
- The novel LFI system successfully performed sequential assay steps with a single sample injection.
- The delayed-release mechanism using ASPM was validated, controlling substrate release for optimal reaction timing.
- The sensor's performance was demonstrated by measuring high-sensitivity C-reactive protein (hs-CRP) levels in human serum.
Conclusions:
- A simplified, automated chemiluminescent LFI-EIA system was successfully developed.
- The use of ASPM for delayed substrate release offers a cost-effective and user-friendly approach for POCT.
- This technology has potential for sensitive and efficient detection of biomarkers in clinical diagnostics.

